S9630, Medroxyprogesterone in Treating Women With Breast Cancer
Completed · Phase 3
Conditions studied: Breast Cancer, Endometrial Cancer
In brief
RATIONALE: It is not yet known whether medroxyprogesterone is effective in preventing endometrial disorder in patients with breast cancer who are taking tamoxifen. PURPOSE: Randomized phase III trial to study the effectiveness of medroxyprogesterone in preventing endometrial disorder in postmenopausal women who have ductal carcinoma in situ, lobular carcinoma in situ, Paget's disease of the nipple, stage I breast cancer, or stage II breast cancer and who are taking tamoxifen.
Key facts
- Study ID
- NCT00002920
- Run by
- SWOG Cancer Research Network
- People needed
- 313
- Starts
- 1997-03-01
- Expected to finish
- 2009-12-01
- Last updated by the study team
- 2012-10-31
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Providence Alaska Medical Center — Anchorage, Alaska, United States
- CCOP - Western Regional, Arizona — Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Phoenix (Carl T. Hayden) — Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Tucson — Tucson, Arizona, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center — Tucson, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
- Veterans Affairs Medical Center - Little Rock — Little Rock, Arkansas, United States
- City of Hope Comprehensive Cancer Center — Duarte, California, United States
- Rebecca and John Moores UCSD Cancer Center — La Jolla, California, United States
- Veterans Affairs Medical Center - Loma Linda (Pettis) — Loma Linda, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital — Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
- Veterans Affairs Outpatient Clinic - Martinez — Martinez, California, United States
- CCOP - Bay Area Tumor Institute — Oakland, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center — Orange, California, United States
- University of California Davis Cancer Center — Sacramento, California, United States
- Naval Medical Center - San Diego — San Diego, California, United States
- CCOP - Santa Rosa Memorial Hospital — Santa Rosa, California, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center — Aurora, Colorado, United States
- Veterans Affairs Medical Center - Denver — Denver, Colorado, United States
- CCOP - Christiana Care Health Services — Newark, Delaware, United States
- Lombardi Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia, United States
- MBCCOP - Howard University Cancer Center — Washington D.C., District of Columbia, United States
- Broward General Medical Center — Fort Lauderdale, Florida, United States
- MBCCOP - Gulf Coast — Mobile, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.